Figure 12: Differentiation of embryoid bodies, as the means to determine pluripotency, was conducted for the cells acquired from the primary tumors of the patients diagnosed with the embryonal carcinoma of the testes (huECT bio) (the patients encoded 001-009, which are labeled in this figure as A-I respectively) and the cultured human embryonic stem cell lines (H1, H13 huESC cc, as J-K). Expression detected: +; no expression detected: -; lost sample: L.